Rational design of potent sialidase-based inhibitors of influenza virus replication

von Itzstein, Mark, Wu, Wen-Yang, Kok, Gaik B., Pegg, Michael S., Dyason, Jeffrey C., Jin, Betty, Van Phan, Tho, Smythe, Mark L., White, Hume F., Oliver, Stuart W., Colman, Peter M., Varghese, Joseph N., Ryan, D. Michael, Woods, Jacqueline M., Bethell, Richard C., Hotham, Vanessa J., Cameron, Janet M., Penn, Charles R.·1993·Nature
DOI 10.1038/363418a0

Cited by (1,001)

Items 501–600 of 1,001

  1. Novel inhibitors of influenza sialidase related to GG167 Synthesis of 4-amino and guanidino-4H-pyran-2-carboxylic acid-6-propylamides; selective inhibitors of influenza a virus sialidase
    Steven L. Sollis, Paul W. Smith, Peter D. Howes, Peter C. Cherry, Richard C. Bethell · 1996 · Bioorganic & Medicinal Chemistry Letters
  2. Antivirals against animal viruses
    Tomás G. Villa, Lucía Feijoo-Siota, José Luis R. Rama, José Manuel Ageitos · 2016 · Biochemical Pharmacology
  3. Iminosugars: Promising therapeutics for influenza infection
    Beatrice E. Tyrrell, Andrew C. Sayce, Kelly Lyn Warfield, Joanna L. Miller, Nicole Zitzmann · 2016 · Critical Reviews in Microbiology
  4. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains
    Woo-Jin Shin, Baik Lin Seong · 2018 · Expert Opinion on Drug Discovery
  5. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease
    João Neres, Richard A. Bryce, Kenneth Thomas Douglas · 2008 · Drug Discovery Today
  6. Computer modeling of substrate binding to lipases from Rhizomucor miehei, Humicola lanuginosa, and Candida rugosa
    Martin Norin, Fredrik Hæffner, Adnane Achour, Torbjörn Norin, Karl Hult · 1994 · Protein Science
  7. Anti-Influenza Drugs: The Development of Sialidase Inhibitors
    Mark von Itzstein, Robin J. Thomson · 2008 · Handbook of experimental pharmacology
  8. Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry
    Kavya Swaminathan, Jeffrey C. Dyason, Andrea Maggioni, Mark von Itzstein, Kevin M. Downard · 2013 · Analytical and Bioanalytical Chemistry
  9. Sialyllactose-Modified Three-Way Junction DNA as Binding Inhibitor of Influenza Virus Hemagglutinin
    Miyuki Yamabe, Kunihiro Kaihatsu, Yasuhito Ebara · 2018 · Bioconjugate Chemistry
  10. Site‐directed mutagenesis of catalytic residues of influenza virus neuraminidase as an aid to drug design
    Anita A. Ghate, Gillian M. Air · 1998 · European Journal of Biochemistry
  11. Divergent evolution of hemagglutinin and neuraminidase genes in recent influenza A:H3N2 viruses isolated in Canada
    Yacine Abed, Isabelle Hardy, Yan Li, Guy Boivin · 2002 · Journal of Medical Virology
  12. Recent Advances in Ligand Design Methods
    Mark A. Murcko · 1997 · Reviews in computational chemistry
  13. Interactive molecular dynamics in virtual reality for accurate flexible protein-ligand docking
    Helen M. Deeks, Rebecca K. Walters, Stephanie R. Hare, Michael B. O’Connor, Adrian John Mulholland, David R. Glowacki · 2020 · PLoS ONE
  14. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes
    Kosuke Okuya, Reiko Yoshida, Rashid Manzoor, Shinji Saito, Tadaki Suzuki, Michihito Sasaki, Takeshi Saito, Yurie Kida, Akina Mori‐Kajihara, Tatsunari Kondoh et al. · 2020 · Journal of Virology
  15. Pathogenesis and pathology of blackleg in ruminants: The role of toxins and neuraminidase. A short review
    N. M. Useh, Andrew Jonathan Nok, K.A.N. Esievo · 2003 · Veterinary Quarterly
  16. Development of Oseltamivir Phosphonate Congeners as Anti-influenza Agents
    Ting-Jen Rachel Cheng, Steven P. Weinheimer, E. Bart Tarbet, Jia‐Tsrong Jan, Yih‐Shyun E. Cheng, Jiun‐Jie Shie, Chunlin Chen, Chih-An Chen, Wei-Che Hsieh, Pei-Wei Huang et al. · 2012 · Journal of Medicinal Chemistry
  17. Application of computational methods for anticancer drug discovery, design, and optimization
    Diego Prada‐Gracia, Sara Huerta‐Yépez, Liliana Marisol Moreno‐Vargas · 2016 · Boletín Médico Del Hospital Infantil de México (English Edition)
  18. Structure-activity relationships of carbocyclic influenza neuraminidase inhibitors
    Matthew A. Williams, Willard Lew, Dirk B. Mendel, Chun Y. Tai, Paul A. Escarpe, William Graeme Laver, Raymond C. Stevens, Choung U. Kim · 1997 · Bioorganic & Medicinal Chemistry Letters
  19. Predicting the structure of protein complexes: a step in the right direction
    Brian K. Shoichet, Irwin D. Kuntz · 1996 · Chemistry & Biology
  20. High throughput virus plaque quantitation using a flatbed scanner
    Kate H. Sullivan, Johannes Kloess, Chen Qian, Donald M. Bell, Alan J Hay, Yi Pu Lin, Yan Gu · 2011 · Journal of Virological Methods
  21. A proteomics approach to survey the antigenicity of the influenza virus by mass spectrometry
    Bethny Morrissey, Kevin M. Downard · 2006 · PROTEOMICS
  22. Has Molecular Docking Ever Brought us a Medicine?
    Mark Andrew Phillips, Marisa A. Stewart, Darby L. Woodling, Zhong‐Ru Xie · 2018 · InTech eBooks
  23. Synthesis of optically active amino sugar derivatives using catalytic enantioselective hetero-Diels–Alder reactions
    Wei Zhuang, Jacob Thorhauge, Karl Anker Jørgensen · 2000 · Chemical Communications
  24. Enzyme in der organischen Synthese: das Problem der molekularen Erkennung von Kohlenhydraten (Teil 2)
    Chi‐Huey Wong, Randall L. Halcomb, Yoshitaka Ichikawa, Tetsuya Kajimoto · 1995 · Angewandte Chemie
  25. Biotechnological production and applications of N-acetyl-d-neuraminic acid: current state and perspectives
    Fei Tao, Yinan Zhang, Cuiqing Ma, Ping Xu · 2010 · Applied Microbiology and Biotechnology
  26. Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl α(2→3) lactose moieties as inhibitors for human influenza viruses
    Hiroyuki Oka, Tomotsune Onaga, Tetsuo Koyama, Chao-tan Guo, Yasuo Suzuki, Yasuaki Esumi, Ken Hatano, Daiyo Terunuma, Koji Matsuoka · 2009 · Bioorganic & Medicinal Chemistry
  27. Frequency of Drug-resistant Viruses and Virus Shedding in Pediatric Influenza Patients Treated With Neuraminidase Inhibitors
    Daisuke Tamura, Norio Sugaya, Makoto Ozawa, Ryo Takano, Masataka Ichikawa, Masahiko Yamazaki, Chiharu Kawakami, Hideaki Shimizu, Ritei Uehara, Maki Kiso et al. · 2011 · Clinical Infectious Diseases
  28. Synthesis and Anti-influenza Evaluation of Polyvalent Sialidase Inhibitors Bearing 4-Guanidino-Neu5Ac2en Derivatives
    Takeshi Masuda, Shuku Yoshida, Masami Arai, Satoru Kaneko, Makoto Yamashita, Takeshi Honda · 2003 · Chemical and Pharmaceutical Bulletin
  29. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant
    Jian Zhang, N. Arul Murugan, Ye Tian, Chiara Bertagnin, Zengjun Fang, Dongwei Kang, Xiujie Kong, Haiyong Jia, Zhuosen Sun, Ruifang Jia et al. · 2018 · Journal of Medicinal Chemistry
  30. Identification of Chebulinic Acid and Chebulagic Acid as Novel Influenza Viral Neuraminidase Inhibitors
    Ping Li, Ruikun Du, Yanyan Wang, Xuewen Hou, Lin Wang, Xiujuan Zhao, Peng Zhan, Xinyong Liu, Lijun Rong, Qinghua Cui · 2020 · Frontiers in Microbiology
  31. Mutations in Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Causing Increased Receptor Binding Activity and Resistance to the Transition State Sialic Acid Analog 4-GU-DANA (Zanamivir)
    Matthew T. Murrell, Matteo Porotto, Thomas Weber, Olga Greengard, Anne Moscona · 2002 · Journal of Virology
  32. Creation of a Tailored Aldolase for the Parallel Synthesis of Sialic Acid Mimetics
    Thomas Woodhall, Gavin J. Williams, Alan Berry, Adam S. Nelson · 2005 · Angewandte Chemie International Edition
  33. Synthesis of a Novel Sialic Acid Derivative (Sialylphospholipid) as an Antirotaviral Agent
    Mamoru Koketsu, Teruhiko Nitoda, Hidetoshi Sugino, Lekh Raj Juneja, Mujo Kim, Takehiko Yamamoto, Naoji Abe, Tetsuya Kajimoto, Chi‐Huey Wong · 1997 · Journal of Medicinal Chemistry
  34. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-guanidino-Neu5Ac2en (GG167) with modified 5-substituents
    PW Smith, Ian D. Starkey, P. D. HOWES, Steven L. Sollis, Steven P. Keeling, PC Cherry, Mark von Itzstein, WY Wu, Betty Jin · 1996 · European Journal of Medicinal Chemistry
  35. Generation and Characterization of a Mutant of Influenza A Virus Selected with the Neuraminidase Inhibitor BCX-140
    Shanta Bantia, Anita A. Ghate, Sandya L. Ananth, Yarlagadda S. Babu, Gillian M. Air, Gerald M. Walsh · 1998 · Antimicrobial Agents and Chemotherapy
  36. Prospects for rational approaches to anthelmintic discovery
    David P. Thompson, Ronald D. Klein, Timothy G. Geary · 1996 · Parasitology
  37. Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid
    G.P. Thomas, Morag A. Forsyth, Charles R. Penn, John W. McCauley · 1994 · Antiviral Research
  38. An Approach to the Precise Chemoenzymatic Synthesis of 13C-Labeled Sialyloligosaccharide on an Intact Glycoprotein: A Novel One-Pot [3-13C]-Labeling Method for Sialic Acid Analogues by Control of the Reversible Aldolase Reaction, Enzymatic Synthesis of [3-13C]-NeuAc-α-(2→3)-[U-13C]-Gal-β-(1→4)-GlcNAc-β- Sequence onto Glycoprotein, and Its Conformational Analysis by Developed NMR Techniques
    Tatsuo Miyazaki, Hajime Sato, Tohru Sakakibara, Yasuhiro Kajihara · 2000 · Journal of the American Chemical Society
  39. Antivirals for Pandemic Influenza
    Frederick G. Hayden · 1997 · The Journal of Infectious Diseases
  40. Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection
    Chia Min Lee, Alisha K. Weight, Jayanta Haldar, Ling Wang, Alexander M. Klibanov, Jianzhu Chen · 2012 · Proceedings of the National Academy of Sciences
  41. Large-scale FMO-MP3 calculations on the surface proteins of influenza virus, hemagglutinin (HA) and neuraminidase (NA)
    Yuji Mochizuki, Katsumi Yamashita, Kaori Fukuzawa, Kazutomo Takematsu, Hirofumi Watanabe, Naoki Taguchi, Yoshio Okiyama, Misako Tsuboi, Tatsuya Nakano, Shigenori Tanaka · 2010 · Chemical Physics Letters
  42. Dynamic Behavior of Avian Influenza A Virus Neuraminidase Subtype H5N1 in Complex with Oseltamivir, Zanamivir, Peramivir, and Their Phosphonate Analogues
    Thanyarat Udommaneethanakit, Thanyada Rungrotmongkol, Urban Bren, Vladimı́r Frecer, Stanislav Miertuš · 2009 · Journal of Chemical Information and Modeling
  43. Design of Multi-Binding-Site Inhibitors, Ligand Efficiency, and Consensus Screening of Avian Influenza H5N1 Wild-Type Neuraminidase and of the Oseltamivir-Resistant H274Y Variant
    Alfonso T. García‐Sosa, Sulev Sild, Uko Maran · 2008 · Journal of Chemical Information and Modeling
  44. Oseltamivir-resistant influenza?
    Anne Moscona · 2004 · The Lancet
  45. Coadministration of Orally Inhaled Zanamivir with Inactivated Trivalent Influenza Vaccine Does Not Adversely Affect the Production of Antihaemagglutinin Antibodies in the Serum of Healthy Volunteers
    Alison Webster, Malcolm J. Boyce, Sally Edmundson, Irene A. Miller · 1999 · Clinical Pharmacokinetics
  46. Rational multivalency construction enables bactericidal effect amplification and dynamic biomaterial design
    Xu Chen, Xinrui Li, Wenbo He, Miao Wang, Ang Gao, Liping Tong, Shun Guo, Huaiyu Wang, Guoqing Pan · 2023 · The Innovation
  47. Clarithromycin Inhibits Progeny Virus Production from Human Influenza Virus-Infected Host Cells
    Daisei Miyamoto, Sayaka Hasegawa, Nongluk Sriwilaijaroen, Sangchai Yingsakmongkon, Hiroaki Hiramatsu, Tadanobu Takahashi, Kazuya I.P.J. Hidari, Chao-tan Guo, Yuichi Sakano, Takashi Suzuki et al. · 2008 · Biological and Pharmaceutical Bulletin
  48. Systematic syntheses of influenza neuraminidase inhibitors: A series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties
    Jun-Ichi Sakamoto, Tetsuo Koyama, Daisei Miyamoto, Sangchai Yingsakmongkon, Kazuya I.P.J. Hidari, Wipawee Jampangern, Takashi Suzuki, Yasuo Suzuki, Yasuaki Esumi, Takemichi Nakamura et al. · 2009 · Bioorganic & Medicinal Chemistry
  49. Streptococcus pneumoniae NanC
    Callum D. Owen, Petra Lukacik, Jane A. Potter, O.K. Sleator, Garry L. Taylor, Martin Austin Walsh · 2015 · Journal of Biological Chemistry
  50. Carbohydrates in diversity-oriented synthesis: challenges and opportunities
    Elena Lenci, Gloria Menchi, Andrea Trabocchi · 2015 · Organic & Biomolecular Chemistry
  51. Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors
    Pengcheng Wang, Jim‐Min Fang, Keng‐Chang Tsai, Shiyun Wang, Wen‐I Huang, Yin‐Chen Tseng, Yih‐Shyun E. Cheng, Ting-Jen Rachel Cheng, Chi‐Huey Wong · 2016 · Journal of Medicinal Chemistry
  52. Microglial activation by microbial neuraminidase through TLR2 and TLR4 receptors
    María del Mar Fernández‐Arjona, Jesús M. Grondona, Pedro Fernández‐Llebrez, María Dolores López-Ávalos · 2019 · Journal of Neuroinflammation
  53. A Novel Approach to the Design of Inhibitors of Human Secreted Phospholipase A2 Based on Native Peptide Inhibition
    William Bret Church, Adam S. Inglis, Albert Tseng, Ray Duell, Pei-Wen Lei, Katherine J. Bryant, Kieran F. Scott · 2001 · Journal of Biological Chemistry
  54. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir
    Lindsey Cass, Kulasiri A. Gunawardena, Mark MacMahon, Alan Bye · 2000 · Respiratory Medicine
  55. Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus
    Siwen Niu, Longlong Si, Dong Liu, Andrew Zhou, Ziwei Zhang, Zongze Shao, Shaomeng Wang, Lihe Zhang, Demin Zhou, Wenhan Lin · 2015 · European Journal of Medicinal Chemistry
  56. Modelling the reaction course of N-acetylneuraminic acid synthesis from N-acetyl-d-glucosamine—new strategies for the optimisation of neuraminic acid synthesis
    Vera Zimmermann, Hans‐Georg Hennemann, Thomas Daußmann, Udo Kragl · 2007 · Applied Microbiology and Biotechnology
  57. Carbohydrate-Based Therapeutics
    Snigdha Mishra, K. Upadhaya, Kunj B. Mishra, Akhilesh K. Shukla, Rama Pati Tripathi, Vinod K. Tiwari · 2016 · Studies in natural products chemistry
  58. All Eight Stereoisomeric d -Glyconic-δ-lactams: Synthesis, Conformational Analysis, and Evaluation as Glycosidase Inhibitors
    Yoshio Nishimura, Hayamitsu Adachi, Takahiko Satoh, Eiki Shitara, Hikaru Nakamura, Fukiko Kojima, TOMIO TAKEUCHI · 2000 · The Journal of Organic Chemistry
  59. Human-Like Receptor Specificity Does Not Affect the Neuraminidase-Inhibitor Susceptibility of H5N1 Influenza Viruses
    Natalia A. Ilyushina, Elena A. Govorkova, Thomas E. Gray, Nicolai Vladimirovich Bovin, Robert G. Webster · 2008 · PLoS Pathogens
  60. A strategy for theoretical binding constant, Ki, calculations for neuraminidase aromatic inhibitors designed on the basis of the active site structure of influenza virus neuraminidase
    Marek J. Jedrzejas, Sangeeta Singh, Wayne J. Brouillette, Gillian M. Air, Ming Luo · 1995 · Proteins Structure Function and Bioinformatics
  61. Was läßt sich aus der molekularen Erkennung in Protein‐Ligand‐Komplexen für das Design neuer Wirkstoffe lernen?
    Hans‐Joachim Böhm, Gerhard Klebe · 1996 · Angewandte Chemie
  62. Synthesis of a Phosphonate Analog of Sialic Acid (Neu5Ac) Using Indium-Mediated Allylation of Unprotected Carbohydrates in Aqueous Media
    Jinming Gao, Valeri Martichonok, George M. Whitesides · 1996 · The Journal of Organic Chemistry
  63. Synthesis of 6-, 7- and 8-carbon sugar analogues of potent anti-influenza 2,3-didehydro-2,3-dideoxy-N-acetylneuraminic acid derivatives
    Mark J. Bamford, Julia Castro‐Pichel, Wahid Husman, Bina Patel, Richard Storer, Niall G. Weir · 1995 · Journal of the Chemical Society Perkin Transactions 1
  64. Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en
    Takeshi Honda, Shuku Kubo, Takeshi Masuda, Masami Arai, Yoshiyuki Kobayashi, Makoto Yamashita · 2009 · Bioorganic & Medicinal Chemistry Letters
  65. Molecular interaction fields in drug discovery: recent advances and future perspectives
    Anna Artese, Simon Cross, Giosuè Costa, Simona Distinto, Lucia Parrotta, Stefano Alcaro, Francesco Ortuso, Gabriele Cruciani · 2013 · Wiley Interdisciplinary Reviews Computational Molecular Science
  66. Large-Scale Structural Biology of the Human Proteome
    A.M. Edwards · 2009 · Annual Review of Biochemistry
  67. Production of N -Acetyl- d -Neuraminic Acid by Use of an Efficient Spore Surface Display System
    Xiaoman Xu, Chao Gao, Xifeng Zhang, Bin Che, Cuiqing Ma, Jianhua Qiu, Fei Tao, Ping Xu · 2011 · Applied and Environmental Microbiology
  68. Characterization of the Chemoenzymatic Synthesis of N‐Acetyl‐ d ‐neuraminic Acid (Neu5Ac)
    Simone Blayer, John M. Woodley, MALCOLM D. LILLY, Michael J. Dawson · 1996 · Biotechnology Progress
  69. Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses
    Philippe François Simon, Marc-Antoine de La Vega, Éric Paradis, Emelissa J. Mendoza, Kevin M. Coombs, Darwyn Kobasa, Catherine A. A. Beauchemin · 2016 · Scientific Reports
  70. Neuraminidase Inhibitors and their Role in Avian and Pandemic Influenza
    Martín Crusat, Menno D. de Jong · 2007 · Antiviral Therapy
  71. Development of Carbohydrate-Based Scaffolds for Restricted Presentation of Recognition Groups. Extension to Divalent Ligands and Implications for the Structure of Dimerized Receptors
    Paul V. Murphy, Helena Bradley, Manuela Tosin, Nigel Pitt, Geraldine M. Fitzpatrick, WILLIAM K. GLASS · 2003 · The Journal of Organic Chemistry
  72. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase
    João Neres, Pascal Bonnet, Philip N. Edwards, Pravin L. Kotian, Alejandro Buschiazzo, Pedro M. Alzari, Richard A. Bryce, Kenneth Thomas Douglas · 2006 · Bioorganic & Medicinal Chemistry
  73. Sialic Acid as Receptor Determinant of Ortho- and Paramyxoviruses
    Georg Herrler, Jürgen Hausmann, Hans‐Dieter Klenk · 1995 · Springer eBooks
  74. In vitro Inhibitory Effects of Combinations of anti-Influenza Agents
    Lisa K. Madren, Charles Shipman, Frederick G. Hayden · 1995 · Antiviral chemistry & chemotherapy
  75. Influenza virus resistance to neuraminidase inhibitors
    Dirk B. Mendel, Robert W. Sidwell · 1998 · Drug Resistance Updates
  76. Protein Structure from X-Ray Diffraction
    Michael W. Parker · 2003 · Journal of Biological Physics
  77. An efficient method for N-acetyl-d-neuraminic acid production using coupled bacterial cells with a safe temperature-induced system
    Yinan Zhang, Fei Tao, Miaofen Du, Cuiqing Ma, Jianhua Qiu, Lichuan Gu, Xiaofei He, Ping Xu · 2009 · Applied Microbiology and Biotechnology
  78. Sialidase and Sialyltransferase Inhibitors: Targeting Pathogenicity and Disease
    W Bowles, T.M. Gloster · 2021 · Frontiers in Molecular Biosciences
  79. Application of Ugi Reactions in Synthesis of Divalent Neoglycoconjugates: Evidence That the Sugars Are Presented in Restricted Conformation
    Helena Bradley, Geraldine M. Fitzpatrick, WILLIAM K. GLASS, Horst Kunz, Paul V. Murphy · 2001 · Organic Letters
  80. The hen's egg yolk: a source of biologically active substances
    C. Hartmann, Martin Wilhelmson · 2001 · World s Poultry Science Journal
  81. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain
    David M. Andrews, Peter C. Cherry, David C. Humber, Paul S. Jones, Steven P. Keeling, Paul F. Martin, Caroline D Shaw, Stephen Swanson · 1999 · European Journal of Medicinal Chemistry
  82. Systematic placement of structural water molecules for improved scoring of protein-ligand interactions
    David J. Huggins, Bruce Tidor · 2011 · Protein Engineering Design and Selection
  83. Synthesis of Glycophostones: Cyclic Phosphonate Analogues of Biologically Relevant Sugars
    Stephen Hanessian, Olivier Rogel · 2000 · The Journal of Organic Chemistry
  84. Role of Phosphatidylserine Exposure and Sugar Chain Desialylation at the Surface of Influenza Virus-infected Cells in Efficient Phagocytosis by Macrophages
    Yuichi Watanabe, Akiko Shiratsuchi, Kazufumi Shimizu, Takenori Takizawa, Yoshinobu Nakanishi · 2002 · Journal of Biological Chemistry
  85. Programmable One-Pot Glycosylation
    Chung‐Yi Wu, Chi‐Huey Wong · 2010 · Topics in current chemistry
  86. Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs
    Roberto Gasparini, Daniela Amicizia, Piero Luigi Lai, Nicola Luigi Bragazzi, Donatella Panatto · 2015 · Journal of preventive medicine and hygiene
  87. Recent Advances in Computer-Aided Drug Design as Applied to Anti-Influenza Drug Discovery
    Prema Latha Mallipeddi, Gyanendra Kumar, Stephen W. White, Thomas R. Webb · 2014 · Current Topics in Medicinal Chemistry
  88. Design of a Mechanism‐Based Probe for Neuraminidase To Capture Influenza Viruses
    Chun‐Ping Lu, Chien‐Tai Ren, Yi‐Ning Lai, Shih‐Hsiung Wu, Wei‐Man Wang, Jean‐Yin Chen, Lee‐Chiang Lo · 2005 · Angewandte Chemie International Edition
  89. Substrate-Assisted and Nucleophilically Assisted Catalysis in Bovine α1,3-Galactosyltransferase. Mechanistic Implications for Retaining Glycosyltransferases
    Hansel Gómez, José M. Lluch, Laura Masgrau · 2013 · Journal of the American Chemical Society
  90. Highly specific and rapid glycan based amperometric detection of influenza viruses
    Xikai Cui, Amrita Das, Abasaheb N. Dhawane, Joyce A. Sweeney, Xiaohu Zhang, Vasanta Chivukula, Suri S. Iyer · 2017 · Chemical Science
  91. Structure based virtual screening for identification of potential quorum sensing inhibitors against LasR master regulator in Pseudomonas aeruginosa
    Manmohit Kalia, Pradeep Kumar Singh, Vivek Kumar Yadav, Birendra Singh Yadav, Deepmala Sharma, Shahid S. Narvi, Ashutosh Mani, Vishnu Kumar Agarwal · 2017 · Microbial Pathogenesis
  92. Lectin engineering: the possible and the actual
    Jun Hirabayashi, Ryoichi Arai · 2019 · Interface Focus
  93. Bioisosteres of Carbohydrate Functional Groups in Glycomimetic Design
    Rachel Hevey · 2019 · Biomimetics
  94. Natural products against acute respiratory infections: Strategies and lessons learned
    Julia Langeder, Ulrike Grienke, Ya Chen, Johannes Kirchmair, Michaela Schmidtke, Judith Maria Rollinger · 2019 · Journal of Ethnopharmacology
  95. β-d-Glycosylamidines
    Wenfei Guo, Jun Hiratake, Koichi Ogawa, Mikio Yamamoto, Seung‐Jin Ma, Kanzo Sakata · 2001 · Bioorganic & Medicinal Chemistry Letters
  96. Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis
    Jiaying Sun, Shao-Xi Cai, Ning Yan, Mei Ying Hu · 2009 · European Journal of Medicinal Chemistry
  97. Discovery of anti-influenza A virus activity of a corynanthe-type indole alkaloid, hirsutine, in vitro and the structure-activity relationship of natural and synthetic analogs
    Hiromitsu Takayama, Yasuo Iimura, Mariko Kitajima, Norio Aimi, Kenji Konno, Hiroshi Inoue, Masatoshi Fujiwara, Tadashi Mizuta, Tomoyuki Yokota, Shirô Shigeta et al. · 1997 · Bioorganic & Medicinal Chemistry Letters
  98. GS4071 Is a Slow-Binding Inhibitor of Influenza Neuraminidase from Both A and B Strains
    Warren M. Kati, Ayda C. Saldivar, Fariborz Mohamadi, Hing Leung Sham, William Graeme Laver, William E. Kohlbrenner · 1998 · Biochemical and Biophysical Research Communications
  99. Current computational tools for de novo ligand design
    Hans‐Joachim Böhm · 1996 · Current Opinion in Biotechnology
  100. Integrating molecular modelling methods to advance influenza A virus drug discovery
    Hershna Patel, Andreas Kukol · 2020 · Drug Discovery Today